The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...nt solutions for improved outcomes.
more
Hesperian released a Coronavirus (COVID-19) Fact Sheet specifically for people like you, individuals and organizations seeking credible resources. Thanks to the incredible skill and participation of many partners on short notice, it is available now in English, Spanish, French, Chinese, Urdu, Bangla..., Filipino, Vietnamese, Bahasa Indonesia, Farsi, Sindhi, Telugu, and Hindi on the website. Fact sheets in Shona, Portuguese, Arabic, and Chichewa are on the way.
more
This visual story was created for kids to better understand the 2019 novel coronavirus and the COVID-19 illness it causes.
Lifeology is a platform that brings together scientists, artists, writers and broader audiences in the creation of educational content including mobile-friendly Lifeology min...i-courses that can reach anyone.
more
country brief, Syrian Arab Republic
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...ons and duration of hospital stay. Both the South African Thoracic Society (SATS) and Global Initiative for Chronic Obstructive Lung Disease (GOLD), guidelines recommend the use of long acting anticholinergic drugs (or long acting beta agonists) in moderate to very severe disease as defined by lung function (FEV1). The most up to date guideline, utilizing the GRADE methodology (European Respiratory Society guidelines of 2017), confirms their superiority over long acting β agonists (LABA) as monotherapy for COPD in that LAMA's have demonstrated greater efficacy in terms of exacerbation reduction, with similar safety profile.2 These recommnedations are supported by published peer-reviewed
evidence including individual papers and Cochrane reviews.
more
Who is Covid? What is it doing in town? And how can we keep it away?
This visual story was created for kids to better understand the 2019 novel coronavirus and the COVID-19 illness it causes. Written by Signe Elisabeth Aasberg, PhD, illustrated by Elfy Chiang, presented by Lifeology, reviewed by... our children.
more
National Tuberculosis and Leprosy control Program